Pharmacotherapy in the treatment of male sexual dysfunction

Journal of Sex Research

Volumn 37, Issue 3, 2000, Pages 226-243

  Rowland, David L ^a   Burnett, Arthur L ^b  

^a VALPARAISO UNIVERSITY   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; ALIBRA; APOMORPHINE; BIMIX; BIMIX ANDROSKAT; CLOMIPRAMINE; EMLA; FLUOXETINE; FLUVOXAMINE MALEATE; GLYCERYL TRINITRATE; INVICORP; MINOXIDIL; MOXISYLYTE; PAPAVERINE; PAROXETINE; PHENOXYBENZAMINE; PHENTOLAMINE; PHENTOLAMINE MESYLATE; PRAZOSIN; PROPRANOLOL; PROSTAGLANDIN E1; PROSTAVASIN; SERTRALINE; SILDENAFIL; TERAZOSIN; TRAZODONE; TRIMIX; VASOACTIVE INTESTINAL POLYPEPTIDE; YOHIMBINE; YOLON;

DRUG EFFICACY; DRUG USE; ERECTILE DYSFUNCTION; HUMAN; MALE; MALE SEXUAL DYSFUNCTION; PENIS ERECTION; PREMATURE EJACULATION; REVIEW; SEXUAL FUNCTION;

EID: 0033672823     PISSN: 00224499     EISSN: None     Source Type: Journal    
DOI: 10.1080/00224490009552043     Document Type: Review

References (144)

1. Is vasoactive intestinal polypeptide the principal transmitter involved in human penile erection?
2. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior
3. Pharmacologic treatment of rapid ejaculation
4. A double blind crossover trial of clomipramine for rapid ejaculation in 15 couples
5. Physiology of penile erection
6. Fluvoxamine-induced erectile dysfunction responding to sildenafil
7. Vasoactive pharmacotherapy
8. Sexual side effects of clomipramine (Anafranil)
9. Penile hemodynamic findings with the new topical formulation of alprostadil
10. Effect of an alpha-blocking agent (phenoxybenzamine) in the management of premature ejaculation
11. Efficacy of prilocaine-lidocaine cream in the treatment of premature ejaculation
12. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction
13. An analysis of 653 trials of penile vibratory stimulation in men with spinal cord injury
14. The effects of papaverine on the electrical and mechanical activity of the guinea-pig ureter
15. Erectile dysfunction: A practical approach for primary care
16. Neurophysiology of erectile function and dysfunction
17. Treatment of impotence with intracavernous auto-injections: Moxisylyte diminishes the risks compared to papaverine
18. Double-blind multicenter study comparing alprostadil alphacyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction
19. Safety of intracavernous injections using an alpha-blocking agent
20. Minoxidil versus nitroglycerine: A prospective, double-blind controlled trial in transcutaneous erection facilitation for organic impotence
21. Alpha-1 blockade pharmacotherapy in primitive psychogenic premature ejaculation resistant to psychotherapy
22. The penis as a vascular organ: The importance of corporal smooth muscle tone in the control of erection
23. Suppression of copulatory behaviour in the male rats following central administration of clonidine
24. Psychotropic drug-induced sexual function disorders
25. A clinical trial of the beta blocker propranolol in premature ejaculation
26. Efficiency and side effects of intracavernous injections of moxisylyte in impotent patients: A dose-finding study versus placebo
27. Efficacy of transurethral alprostadil (MUSE) vs. transurethral alprostadil/prazosin (Alibra(TM)) in men with complete, organic erectile dysfunction
28. Trazodone is not effective therapy for erectile dysfunction: The results of a placebo controlled, double blind study
29. Premature ejaculation: Use of ethyl amino benzoate to prolong coitus
30. Physiology of male sexual function
31. A new transurethral drug delivery system for erectile dysfunction: Iontophoresis
32. Clomipramine in the treatment of premature ejaculation
33. Yohimbine for erectile dysfunction: A systematic review and meta-analysis of randomized clinical trials
34. Hand and genital sympathetic skin potentials in flaccid and erectile penile states in normal potent men and patients with premature ejaculation
35. Intracavernous medication for treatment of premature ejaculation
36. Stimulation of 5-HT1a and 5-HT1b receptors in brain regions and its effect on male rat sexual behavior
37. Psychotropic medications and their effects on sexual function: Diagnosis, biology, and treatment approaches
38. Neural control of penile erection
39. Efficacy and safety of oral phentolamine (Vasomax) for the treatment of minimal erectile dysfunction [Abstract]
40. Oral sildenafil in the treatment of erectile dysfunction
41. An assessment of clomipramine (Anafranil) in the treatment of premature ejaculation
42. The results of a 6 month multi-center placebo controlled study of Invicorp in the treatment of non-psychogenic erectile dysfunction [Abstract]
43. Fluoxetine and premature ejaculation: A double-blind, crossover, placebo-controlled study
44. Clomipramine and sexual function in men with premature ejaculation and controls
45. Comparative results of goal oriented therapy for erectile dysfunction
46. The Viagra craze
47. Sex therapy research: Has it withered on the vine?
48. Integration of treatments for male erectile dysfunction
49. Recovery of erectile function by the oral administration of apomorphine
50. Topical glyceriltrinitrate causes measurable penile dilation in impotent men
51. Empirically validated treatment for sexual dysfunction
52. A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil
53. Outcome analysis of goal directed therapy for impotence
54. Effects of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro
55. Hemodynamics of papaverine- and phentolamine-induced penile erection
56. The efficacy of fluoxetine in the treatment of premature ejaculation: A double-blind placebo controlled study
57. Ejaculation and emission: Normal physiology, dysfunction, and therapy
58. Penile response to intracavernosal vasoactive intestinal polypeptide alone and in combination with other vasoactive agents
59. Papaverine topical gel for treatment of erectile dysfunction
60. Topical prostaglandin-E1 for the treatment of erectile dysfunction
61. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: A double-blind, placebo controlled study
62. Cardiovascular risk factors and erectile dysfunction
63. Premature emission after spinal cord injury
64. Quantitative relations between cyclic AMP and contraction as affected by stimulators of adenylate cyclase and inhibitors of phosphodiesterase
65. The efficacy of anti-serotoninergic agents in the treatment of erectile dysfunction
66. Transurethral alprostadil for the treatment of erectile dysfunction: Two-year safety update [Abstract]
67. Apomorphine-induced penile tumescence in impotent patients-preliminary findings
68. New drug for erectile dysfunction boon for many, 'viagravation' for some [News]
69. Oral trazodone as empirical therapy for erectile dysfunction: A retrospective review
70. An open clinical trial of fluoxetine in the treatment of premature ejaculation
71. Helping men to control ejaculation
72. Combined use of transurethral alprostadil and an adjustable penile constriction band in men with erectile dysfunction: Results from a multicenter trial
73. Intracavernous prostaglandin E1 in erectile dysfunction
74. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction
75. Treatment of erectile dysfunction in men with diabetes
76. Paroxetine in the treatment of premature ejaculation
77. Physiology of erection and pathophysiology of impotence
78. A role for 5-hydroxytryptamine in descending inhibition of spinal sexual reflexes
79. A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction
80. Treatment of premature ejaculation with sertraline hydrochloride: A single-blind placebo controlled crossover study
81. Treatment of premature ejaculation with sertraline hydrochloride
82. Topical septa/PGE-1 gel for the treatment of erectile dysfunction
83. Sertraline treatment for premature ejaculation
84. Nefazodone-induced spontaneous ejaculation
85. Clinical guidelines panel on erectile dysfunction: Summary report on the treatment of organic erectile dysfunction
86. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction
87. Oral and topical treatment of erectile dysfunction: Present and future
88. Impotence. NIH consensus development panel on impotence
89. Electroejaculation versus vibratory stimulation in spinal cord injured men: Sperm quality and patient preference
90. Efficacy and safety of apormorphine sl vs placebo for male erectile dysfunction (MED)
91. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) study group
92. Characterization of cyclic AMP accumulation in cultured human corpus cavernosum smooth muscle cells
93. Sexologic problems in dermatology
94. Homologies of animal and human sexual behaviors
95. The rationale for prostaglandin E1 in erectile failure: A survey of worldwide experience
96. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine
97. A psychophysiological approach to assessing premature ejaculation
98. The psychosocial context of erectile dysfunction
99. Intracavernosal self-injection therapy in men with erectile dysfunction: Satisfaction and attrition in 119 patients
100. The treatment of premature ejaculation: Psychological and biological strategies
101. The study of ejaculatory response in the psychophysiological laboratory
102. 8-OH-DPAT interacts with sexual experience and testosterone to affect ejaculatory response in the rat
103. Premature ejaculation: Psychophysiological considerations in theory, research, and treatment
104. Ejaculatory latency and control in men with premature ejaculation: An analysis across sexual activities using multiple sources of information
105. A double-blind, placebo controlled trial of the hemodyanamic effects of topical application of the penis of an aqueous nitroglycerin gel in healthy male volunteers
106. A clinical trial of intracavernous vasoactive intestinal peptide to induce penile erection
107. Mechanisms for the regulation of penile smooth muscle contractility
108. Androgens and sexual function in men
109. Anti-depressant induced orgasm disorder
110. Clomipramine versus placebo in the treatment of premature ejaculation: A pilot study
111. Premature ejaculation
112. Evaluation and nonsurgical management of erectile dysfunction
113. The use of phenoxybenzamine in the treatment of premature ejaculation
114. Routine psychophysiological screening of 384 men with erectile dysfunction
115. Incidence and prevalence of the sexual dysfunctions: A critical review of the empirical literature
116. Meta-analysis of the efficacy of sildenafil (Viagra(TM)) in the treatment of severe erectile dysfunction
117. Clomipramine in the treatment of rapid (premature) ejaculation
118. The psychophysiological nature of premature ejaculation
119. Mechanism of relaxant action of papaverine. VI. Sodium ion dependence of its effect on 45Ca-efflux in guinea-pig taenia coli
120. Therapeutic effects of high dose yohimbine hydrochloride on organic erectile dysfunction
121. Ejaculatory disturbances
122. The medicalization of sexuality: Conceptual, normative, and professional issues
123. A systems perspective on sexual desire
124. Intracavernous injection of papaverine for erectile failure
125. Paroxetine treatment of premature ejaculation: A double-blind, randomized, placebo-controlled study
126. Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: A double-blind, randomized, dose-response study
127. Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline
128. The globe is gaga for Viagra
129. MUSE therapy: Preliminary clinical observations
130. Intraurethral prostaglandin E-2 cream: A possible alternative treatment for erectile dysfunction
131. Sexual disorders in the course of clomipramine treatment: A report of three cases
132. Efficacy of a topical agent SS-cream in the treatment of premature ejaculation: Preliminary clinical studies
133. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra)
134. Self-experimentation